Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / BIOTECH ETF
-
Total 13F shares
-
848,206
-
Share change
-
-57,009
-
Total reported value
-
$142,824,724
-
Price per share
-
$168.41
-
Number of holders
-
115
-
Value change
-
-$9,633,264
-
Number of buys
-
33
-
Number of sells
-
41
Institutional Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q2 2024
As of 30 Jun 2024,
VANECK ETF TRUST - BIOTECH ETF (BBH) was held by
115 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
848,206 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, Miller Investment Management, LP, MORGAN STANLEY, WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, Royal Bank of Canada, COMMONWEALTH EQUITY SERVICES, LLC, LPL Financial LLC, UBS Group AG, and NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO.
This page lists
115
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.